172 related articles for article (PubMed ID: 17244805)
21. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
22. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.
Dundar D; Sayan M; Tamer GS
Microb Drug Resist; 2010 Dec; 16(4):279-84. PubMed ID: 20624096
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of macrolide resistant Streptococcus pyogenes isolates from pharyngitis patients in Serbia.
Opavski N; Gajic I; Borek AL; Obszańska K; Stanojevic M; Lazarevic I; Ranin L; Sitkiewicz I; Mijac V
Infect Genet Evol; 2015 Jul; 33():246-52. PubMed ID: 25976381
[TBL] [Abstract][Full Text] [Related]
24. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
[TBL] [Abstract][Full Text] [Related]
25. Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates.
Muhtarova A; Mihova K; Markovska R; Mitov I; Kaneva R; Gergova R
Acta Microbiol Immunol Hung; 2019 Dec; 67(1):14-17. PubMed ID: 31833385
[TBL] [Abstract][Full Text] [Related]
26. Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
Katosova LK; Lazareva AV; Khokhlova TA; Ponomarenko OA; Alyabieva NM
Antibiot Khimioter; 2016 Aug; 61():23-29. PubMed ID: 29874449
[TBL] [Abstract][Full Text] [Related]
27. Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central Italy.
Olivieri R; Morandi M; Zanchi A; Tordini G; Pozzi G; De Luca A; Montagnani F
J Med Microbiol; 2015 Oct; 64(10):1186-1195. PubMed ID: 26224594
[TBL] [Abstract][Full Text] [Related]
28. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
29. Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000-2006 in the Lisbon area.
Pires R; Rolo D; Morais A; Brito-Avô A; Johansson C; Henriques-Normark B; Gonçalo-Marques J; Santos-Sanches I
Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):849-57. PubMed ID: 22012657
[TBL] [Abstract][Full Text] [Related]
30. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.
Silva-Costa C; Pinto FR; Ramirez M; Melo-Cristino J;
Clin Microbiol Infect; 2008 Dec; 14(12):1152-9. PubMed ID: 19046174
[TBL] [Abstract][Full Text] [Related]
31. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
Bejuk D
Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
[TBL] [Abstract][Full Text] [Related]
32. Changes in epidemiologic characteristics and antimicrobial resistance of
Ubukata K; Wajima T; Morozumi M; Sakuma M; Tajima T; Matsubara K; Itahashi K; Iwata S
J Med Microbiol; 2020 Mar; 69(3):443-450. PubMed ID: 32011228
[No Abstract] [Full Text] [Related]
33. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
Chen I; Kaufisi P; Erdem G
J Clin Microbiol; 2011 Jan; 49(1):439-41. PubMed ID: 21068284
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Streptococcus pyogenes from Animal Clinical Specimens, Spain.
Vela AI; Villalón P; Sáez-Nieto JA; Chacón G; Domínguez L; Fernández-Garayzábal JF
Emerg Infect Dis; 2017 Dec; 23(12):2013-2016. PubMed ID: 29148379
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
[TBL] [Abstract][Full Text] [Related]
36. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.
Villaseñor-Sierra A; Katahira E; Jaramillo-Valdivia AN; Barajas-García Mde L; Bryant A; Morfín-Otero R; Márquez-Díaz F; Tinoco JC; Sánchez-Corona J; Stevens DL
Int J Infect Dis; 2012 Mar; 16(3):e178-81. PubMed ID: 22217469
[TBL] [Abstract][Full Text] [Related]
37. Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics.
Sauermann R; Gattringer R; Graninger W; Buxbaum A; Georgopoulos A
J Antimicrob Chemother; 2003 Jan; 51(1):53-7. PubMed ID: 12493787
[TBL] [Abstract][Full Text] [Related]
38. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
[TBL] [Abstract][Full Text] [Related]
39. Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.
Silva-Costa C; Ramirez M; Melo-Cristino J;
J Antimicrob Chemother; 2015 Oct; 70(10):2729-33. PubMed ID: 26142474
[TBL] [Abstract][Full Text] [Related]
40. [Distribution of emm genotypes and antibiotic susceptibility of Streptococcus pyogenes strains: analogy with the vaccine in development].
Arslan U; Oryaşın E; Eskin Z; Türk Dağı H; Fındık D; Tuncer I; Bozdoğan B
Mikrobiyol Bul; 2013 Apr; 47(2):318-23. PubMed ID: 23621731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
